These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Dyslipidemia in type 2 diabetes. Krauss RM; Siri PW Med Clin North Am; 2004 Jul; 88(4):897-909, x. PubMed ID: 15308384 [TBL] [Abstract][Full Text] [Related]
6. [Integrated drug therapy of the metabolic syndrome]. Julius U; Hanefeld M Internist (Berl); 1996 Jul; 37(7):722-30. PubMed ID: 8766266 [No Abstract] [Full Text] [Related]
7. Dyslipidaemia in diabetes--a GP guide. Barnett AH Practitioner; 2002 Feb; 246(1631):120-3. PubMed ID: 11852620 [No Abstract] [Full Text] [Related]
8. [Poseidonol in the treatment of hyperlipidemia in patients with type 2 diabetes mellitus]. Panchenko VM; Ershov AA; Isaev VA; ZImovchenko GS; Chernova GI Klin Med (Mosk); 2001; 79(6):47-9. PubMed ID: 11521381 [TBL] [Abstract][Full Text] [Related]
9. Basic approach to managing hyperglycemia for the nonendocrinologist. Deeg MA Am J Cardiol; 2005 Aug; 96(4A):37E-40E. PubMed ID: 16098842 [TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia. Durrington PN; Tuomilehto J; Hamann A; Kallend D; Smith K Diabetes Res Clin Pract; 2004 May; 64(2):137-51. PubMed ID: 15063607 [TBL] [Abstract][Full Text] [Related]
11. [Drug therapy of hyperglycemia and the prognosis of adult-onset diabetes mellitus]. Niskanen L; Uusitupa M; Laakso M Duodecim; 1999; 115(10):1122-4. PubMed ID: 11877851 [No Abstract] [Full Text] [Related]
12. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476 [TBL] [Abstract][Full Text] [Related]
13. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion? Gulliford MC; Charlton J; Latinovic R J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893 [TBL] [Abstract][Full Text] [Related]
14. Meeting of the minds. Should pre-hypertension in type 2 diabetes be treated? Bihl G; Amod A; Ellis G; Moore R; Raal FJ; Gernholtz T; Schamroth C; Horak A Cardiovasc J Afr; 2010; 21(3 Suppl):S9-S13. PubMed ID: 20532426 [No Abstract] [Full Text] [Related]
15. Drug therapy for hyperlipidemia. Franklin FA; Margolis S Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855 [No Abstract] [Full Text] [Related]
16. [Hyperlipidaemia associated to inaugurated diabetic ketoacidosis]. Matoussi N; Aissa K; Fitouri Z; Cheour M; Ben Becher S Tunis Med; 2006 Oct; 84(10):658-9. PubMed ID: 17193862 [TBL] [Abstract][Full Text] [Related]